Dipeptidyl peptidase-4 (DPP-4): Localization and activity in human and rodent islets

被引:27
作者
Liu, Liehua [1 ,2 ]
Omar, Bilal [2 ]
Marchetti, Piero [3 ]
Ahren, Bo [2 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China
[2] Lund Univ, Dept Clin Sci, SE-22184 Lund, Sweden
[3] Univ Pisa, Dept Clin & Expt Med, Islet Cell Lab, I-56126 Pisa, Italy
基金
英国医学研究理事会;
关键词
Dipeptidyl peptidase 4; Incretin; Islet of Langerhans; Type; 2; diabetes; PROHORMONE CONVERTASE 1/3; PEPTIDE-1; RECEPTOR; ALPHA-CELLS; PANCREAS; GLP-1; IV; EXPRESSION; ENDOCRINE; DIFFERENTIATION; INVOLVEMENT;
D O I
10.1016/j.bbrc.2014.09.096
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Dipeptidyl peptidase 4 (DPP-4) was recently found to be expressed in human and mouse islets with different expression patterns. However, whether species-dependent expression pattern is a generalized phenomenon and whether islet DPP-4 activity is regulated are not known. This study was conducted to investigate DPP-4 localization in several different species, and to examine the impact of glucose, incretin hormones, and insulin on islet DPP-4 activity. It was shown by immuofluorescent staining that there were two distinct species-specific expression patterns of islet DPP-4. The enzyme was expressed exclusively in alpha-cells in human and pig islets, but primarily in beta-cells in mouse and rat islets. INS-1 832/13 cells also expressed DPP-4, and inhibition of DPP-4 enhanced insulin secretion in the presence of glucagon-like peptide-1 (GLP-1) in the cells. DPP-4 activity was remarkably robust when cultured with high glucose, incretin hormones, and insulin in mouse and human islets as well as INS-1 832/13 cells and islet DPP-4 activity and expression pattern was not altered in double incretin receptor knockout mice, compared to wild type mice. We conclude that islet DPP-4 is species-specifically expressed in alpha-cell and beta-cell dominant patterns in several species and both patterns remained robust in enzyme activity during short-term metabolic challenge. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:398 / 404
页数:7
相关论文
共 30 条
[1]
Unique Arrangement of α- and β-Cells in Human Islets of Langerhans [J].
Bosco, Domenico ;
Armanet, Mathieu ;
Morel, Philippe ;
Niclauss, Nadja ;
Sgroi, Antonino ;
Muller, Yannick D. ;
Giovannoni, Laurianne ;
Parnaud, Geraldine ;
Berney, Thierry .
DIABETES, 2010, 59 (05) :1202-1210
[2]
Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action [J].
Campbell, Jonathan E. ;
Drucker, Daniel J. .
CELL METABOLISM, 2013, 17 (06) :819-837
[3]
Over-expression of the glucagon-like peptide-1 receptor on INS-1 cells confers autocrine stimulation of insulin gene promoter activity:: a strategy for production of pancreatic β-cell lines for use in transplantation [J].
Chepurny, OG ;
Holz, GG .
CELL AND TISSUE RESEARCH, 2002, 307 (02) :191-201
[4]
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes [J].
Drucker, Daniel J. ;
Nauck, Michael A. .
LANCET, 2006, 368 (9548) :1696-1705
[5]
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells [J].
Ellingsgaard, Helga ;
Hauselmann, Irina ;
Schuler, Beat ;
Habib, Abdella M. ;
Baggio, Laurie L. ;
Meier, Daniel T. ;
Eppler, Elisabeth ;
Bouzakri, Karim ;
Wueest, Stephan ;
Muller, Yannick D. ;
Hansen, Ann Maria Kruse ;
Reinecke, Manfred ;
Konrad, Daniel ;
Gassmann, Max ;
Reimann, Frank ;
Halban, Philippe A. ;
Gromada, Jesper ;
Drucker, Daniel J. ;
Gribble, Fiona M. ;
Ehses, Jan A. ;
Donath, Marc Y. .
NATURE MEDICINE, 2011, 17 (11) :1481-U1500
[6]
The increased dipeptidyl peptidase-4 activity is not counteracted by optimized glucose control in type 2 diabetes, but is lower in metformin-treated patients [J].
Fadini, G. P. ;
Albiero, M. ;
Menegazzo, L. ;
de Kreutzenberg, S. V. ;
Avogaro, A. .
DIABETES OBESITY & METABOLISM, 2012, 14 (06) :518-522
[7]
Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker [J].
Firneisz, Gabor ;
Varga, Timea ;
Lengyel, Gabriella ;
Feher, Janos ;
Ghyczy, Dora ;
Wichmann, Barna ;
Selmeci, Laszlo ;
Tulassay, Zsolt ;
Racz, Karoly ;
Somogyi, Aniko .
PLOS ONE, 2010, 5 (08)
[8]
Phenotyping of congenic dipeptidyl peptidase 4 (DP4) deficient Dark Agouti (DA) rats suggests involvement of DP4 in neuro-, endocrine, and immune functions [J].
Frerker, Nadine ;
Raber, Kerstin ;
Bode, Felix ;
Skripuletz, Thomas ;
Nave, Heike ;
Klemann, Christian ;
Pabst, Reinhard ;
Stephan, Michael ;
Schade, Jutta ;
Brabant, Georg ;
Wedekind, Dirk ;
Jacobs, Roland ;
Joerns, Anne ;
Forssmann, Ulf ;
Straub, Rainer H. ;
Johannes, Sigrid ;
Hoffmann, Torsten ;
Wagner, Leona ;
Demuth, Hans-Ulrich ;
von Hoersten, Stephan .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (03) :275-287
[9]
Glucose-Dependent Insulinotropic Polypeptide Is Expressed in Pancreatic Islet α-Cells and Promotes Insulin Secretion [J].
Fujita, Yukihiro ;
Wideman, Rhonda D. ;
Asadi, Ali ;
Yang, Gary K. ;
Baker, Robert ;
Webber, Travis ;
Zhang, Tianjiao ;
Wang, Rennian ;
Ao, Ziliang ;
Warnock, Garth L. ;
Kwok, Yin Nam ;
Kieffer, Timothy J. .
GASTROENTEROLOGY, 2010, 138 (05) :1966-U106
[10]
GLUCOSE REGULATION OF DIPEPTIDYL PEPTIDASE IV GENE EXPRESSION IS MEDIATED BY HEPATOCYTE NUCLEAR FACTOR-1α IN EPITHELIAL INTESTINAL CELLS [J].
Gu, Ning ;
Tsuda, Mariko ;
Matsunaga, Tetsuro ;
Adachi, Tetsuya ;
Yasuda, Koichiro ;
Ishihara, Akihiko ;
Tsuda, Kinsuke .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2008, 35 (12) :1433-1439